Reovirus-induced apoptosis requires mitochondrial release of Smac/DIABLO and involves reduction of cellular inhibitor of apoptosis protein levels - PubMed (original) (raw)
Reovirus-induced apoptosis requires mitochondrial release of Smac/DIABLO and involves reduction of cellular inhibitor of apoptosis protein levels
Douglas J Kominsky et al. J Virol. 2002 Nov.
Abstract
Many viruses belonging to diverse viral families with differing structure and replication strategies induce apoptosis both in cultured cells in vitro and in tissues in vivo. Despite this fact, little is known about the specific cellular apoptotic pathways induced during viral infection. We have previously shown that reovirus-induced apoptosis of HEK cells is initiated by death receptor activation but requires augmentation by mitochondrial apoptotic pathways for its maximal expression. We now show that reovirus infection of HEK cells is associated with selective cytosolic release of the mitochondrial proapoptotic factors cytochrome c and Smac/DIABLO, but not the release of apoptosis-inducing factor. Release of these factors is not associated with loss of mitochondrial transmembrane potential and is blocked by overexpression of Bcl-2. Stable expression of caspase-9b, a dominant-negative form of caspase-9, blocks reovirus-induced caspase-9 activation but fails to significantly reduce activation of the key effector caspase, caspase-3. Smac/DIABLO enhances apoptosis through its action on cellular inhibitor of apoptosis proteins (IAPs). Reovirus infection is associated with selective down-regulation of cellular IAPs, including c-IAP1, XIAP, and survivin, effects that are blocked by Bcl-2 expression, establishing the dependence of IAP down-regulation on mitochondrial events. Taken together, these results are consistent with a model in which Smac/DIABLO-mediated inhibition of IAPs, rather than cytochrome c-mediated activation of caspase-9, is the key event responsible for mitochondrial augmentation of reovirus-induced apoptosis. These studies provide the first evidence for the association of Smac/DIABLO with virus-induced apoptosis.
Figures
FIG. 1.
Smac/DIABLO and cytochrome c are present in the cytosol of reovirus-infected cells. HEK 293 lysates were prepared at the indicated time points from mock-infected cells, reovirus-infected cells, or Bcl-2-overexpressing reovirus-infected cells and resolved using SDS-PAGE. Western blot analysis was performed using anti-Smac antibodies (A) and anti-cytochrome c antibodies (B). The Western is representative of two separate experiments. Lanes c, cytoplasmic fraction; lanes m, mitochondrial fraction. h.p.i., hours postinfection.
FIG. 2.
Reovirus infection does not induce the mitochondrial release of AIF. HEK 293 lysates were prepared at the indicated time points from mock-infected and reovirus-infected cells and resolved using SDS-PAGE. Blots were probed with anti-AIF antibodies and are representative of three separate experiments. Lanes c, cytoplasmic fraction; lanes m, mitochondrial fraction. h.p.i., hours postinfection.
FIG. 3.
Mitochondrial ΔΨm is not altered in reovirus-infected cells. HEK 293 cells were mock-infected (A) or infected with reovirus for 0 h (B), 6 h (C), 12 h (D), or 24 h (E). Control cells were treated with valinomycin (panel F). Cells were incubated with the membrane potential-sensitive dye JC-1 and analyzed using flow cytometry. Red fluorescence indicates mitochondria with intact ΔΨm and green fluorescence indicates loss of ΔΨm. Results are representative of three separate experiments.
FIG. 4.
Inhibition of caspase-9 activation does not prevent effector caspase activation. Western blot analysis was performed using HEK 293 lysates harvested at the indicated time points from mock-infected and reovirus-infected cells and probed with anti-caspase-9 antibodies (A) or anti-PARP antibodies (C). Control lanes represent Jurkat cell lysates untreated (−) or treated (+) with activating anti-Fas antibody and harvested at 8 h posttreatment. Each Western blot is representative of two separate experiments. (B) Fluorogenic substrate assays were performed in triplicate. Error bars represent standard error of the mean. Fluorescence is expressed as arbitrary units. h.p.i., hours postinfection.
FIG. 4.
Inhibition of caspase-9 activation does not prevent effector caspase activation. Western blot analysis was performed using HEK 293 lysates harvested at the indicated time points from mock-infected and reovirus-infected cells and probed with anti-caspase-9 antibodies (A) or anti-PARP antibodies (C). Control lanes represent Jurkat cell lysates untreated (−) or treated (+) with activating anti-Fas antibody and harvested at 8 h posttreatment. Each Western blot is representative of two separate experiments. (B) Fluorogenic substrate assays were performed in triplicate. Error bars represent standard error of the mean. Fluorescence is expressed as arbitrary units. h.p.i., hours postinfection.
FIG. 4.
Inhibition of caspase-9 activation does not prevent effector caspase activation. Western blot analysis was performed using HEK 293 lysates harvested at the indicated time points from mock-infected and reovirus-infected cells and probed with anti-caspase-9 antibodies (A) or anti-PARP antibodies (C). Control lanes represent Jurkat cell lysates untreated (−) or treated (+) with activating anti-Fas antibody and harvested at 8 h posttreatment. Each Western blot is representative of two separate experiments. (B) Fluorogenic substrate assays were performed in triplicate. Error bars represent standard error of the mean. Fluorescence is expressed as arbitrary units. h.p.i., hours postinfection.
FIG. 5.
Reovirus infection leads to the cleavage of XIAP. Western blot analysis was performed using HEK 293 lysates harvested at the indicated time points from mock-infected, reovirus-infected, and Bcl-2-overexpressing reovirus-infected cells and probed with anti-XIAP antibodies. Control lanes represent Jurkat cell lysates untreated (−) or treated (+) with activating anti-Fas antibody and harvested at 8 h posttreatment. The Western blot is representative of three separate experiments. h.p.i., hours postinfection.
FIG. 6.
Cellular levels of survivin are reduced following reovirus infection. Western blot analysis was performed using HEK 293 lysates harvested at the indicated time points from mock-infected, reovirus-infected, and Bcl-2-overexpressing reovirus-infected cells and probed with antisurvivin antibodies and antiactin to demonstrate equal protein loading. Control lanes represent Jurkat cell lysates untreated (−) or treated (+) with activating anti-Fas antibody and harvested at 8 h posttreatment. The Western blot is representative of two separate experiments. h.p.i., hours postinfection.
FIG. 7.
Reovirus infection induces a reduction in c-IAP1 protein level. Western blot analysis was performed using HEK 293 lysates harvested at the indicated time points from mock-infected, reovirus-infected, and Bcl-2-overexpressing reovirus-infected cells and probed with anti-c-IAP1 antibodies and antiactin to demonstrate equal protein loading. Control lanes represent Jurkat cell lysates untreated (−) or treated (+) with activating anti-Fas antibody and harvested at 8 h posttreatment. The Western blot is representative of two separate experiments. h.p.i., hours postinfection.
FIG. 8.
Cellular c-IAP2 protein levels are unaffected following reovirus infection. Western blot analysis was performed using HEK 293 lysates harvested at the indicated time points from mock-infected, reovirus-infected, and Bcl-2-overexpressing reovirus-infected cells and probed with anti-c-IAP2 antibodies and antiactin to demonstrate equal protein loading. Control lanes represent Jurkat cell lysates untreated (−) or treated (+) with activating anti-Fas antibody and harvested at 8 h posttreatment. The Western blot is representative of two separate experiments. h.p.i., hours postinfection.
FIG. 9.
Model of cellular pathways involved in reovirus-induced apoptosis in HEK cells. Reovirus infection leads to the activation of caspase-8 and cleavage of the proapoptotic molecule Bid. These events promote the release of Smac/DIABLO and cytochrome c from the mitochondria of infected cells. The release of these proteins can be prevented by the overexpression of Bcl-2. Cytosolic Smac/DIABLO inhibits the antiapoptotic effect exerted by XIAP, survivin, and c-IAP1, leading to the sustained activation of both initiator caspases and the effector caspase, caspase-3. While caspase-9 is activated and undoubtedly participates in reovirus-induced apoptosis, its activation appears to be dispensable for this process.
Similar articles
- Fibroblast growth factor 2-mediated translational control of IAPs blocks mitochondrial release of Smac/DIABLO and apoptosis in small cell lung cancer cells.
Pardo OE, Lesay A, Arcaro A, Lopes R, Ng BL, Warne PH, McNeish IA, Tetley TD, Lemoine NR, Mehmet H, Seckl MJ, Downward J. Pardo OE, et al. Mol Cell Biol. 2003 Nov;23(21):7600-10. doi: 10.1128/MCB.23.21.7600-7610.2003. Mol Cell Biol. 2003. PMID: 14560006 Free PMC article. - Mammalian mitochondrial IAP binding proteins.
Vaux DL, Silke J. Vaux DL, et al. Biochem Biophys Res Commun. 2003 May 9;304(3):499-504. doi: 10.1016/s0006-291x(03)00622-3. Biochem Biophys Res Commun. 2003. PMID: 12729584 Review. - Smac/DIABLO and colon cancer.
Anguiano-Hernandez YM, Chartier A, Huerta S. Anguiano-Hernandez YM, et al. Anticancer Agents Med Chem. 2007 Jul;7(4):467-73. doi: 10.2174/187152007781058631. Anticancer Agents Med Chem. 2007. PMID: 17630921 Review.
Cited by
- The heterogeneous sensitivity of pediatric brain tumors to different oncolytic viruses is predicted by unique gene expression profiles.
Vazaios K, Stavrakaki Ε, Vogelezang LB, Ju J, Waranecki P, Metselaar DS, Meel MH, Kemp V, van den Hoogen BG, Hoeben RC, Chiocca EA, Goins WF, Stubbs A, Li Y, Alonso MM, Calkoen FG, Hulleman E, van der Lugt J, Lamfers MLM. Vazaios K, et al. Mol Ther Oncol. 2024 Apr 15;32(2):200804. doi: 10.1016/j.omton.2024.200804. eCollection 2024 Jun 20. Mol Ther Oncol. 2024. PMID: 38694569 Free PMC article. - Approaches to Evaluating Necroptosis in Virus-Infected Cells.
Lawson CA, Titus DJ, Koehler HS. Lawson CA, et al. Subcell Biochem. 2023;106:37-75. doi: 10.1007/978-3-031-40086-5_2. Subcell Biochem. 2023. PMID: 38159223 - Reovirus Activated Cell Death Pathways.
DeAntoneo C, Danthi P, Balachandran S. DeAntoneo C, et al. Cells. 2022 May 27;11(11):1757. doi: 10.3390/cells11111757. Cells. 2022. PMID: 35681452 Free PMC article. Review. - Egress of non-enveloped enteric RNA viruses.
Owusu IA, Quaye O, Passalacqua KD, Wobus CE. Owusu IA, et al. J Gen Virol. 2021 Mar;102(3):001557. doi: 10.1099/jgv.0.001557. Epub 2021 Feb 9. J Gen Virol. 2021. PMID: 33560198 Free PMC article. Review. - Past, Present and Future of Oncolytic Reovirus.
Müller L, Berkeley R, Barr T, Ilett E, Errington-Mais F. Müller L, et al. Cancers (Basel). 2020 Oct 31;12(11):3219. doi: 10.3390/cancers12113219. Cancers (Basel). 2020. PMID: 33142841 Free PMC article. Review.
References
- Ambrosini, G., C. Adida, and D. C. Altieri. 1997. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat. Med. 3:917-921. - PubMed
- Ashkenazi, A., and V. M. Dixit. 1998. Death receptors: signaling and modulation. Science 281:1305-1308. - PubMed
- Barton, E. S., J. C. Forrest, J. L. Connolly, J. D. Chappell, Y. Liu, F. J. Schnell, A. Nusrat, C. A. Parkos, and T. S. Dermody. 2001. Junction adhesion molecule is a receptor for reovirus. Cell 104:441-451. - PubMed
- Chen, W., P. A. Calvo, D. Malide, J. Gibbs, U. Schubert, I. Bacik, S. Basta, R. O'Neill, J. Schickli, P. Palese, P. Henklein, J. R. Bennink, and J. W. Yewdell. 2001. A novel influenza A virus mitochondrial protein that induces cell death. Nat. Med. 7:1306-1312. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous